Value Partners Group, a Hong Kong-based asset management firm, has announced plans to create a yuan-denominated industry cooperation fund focused on “AI+Life Sciences” in collaboration with three other organizations. The fund aims to foster collaborative investments within the AI and life sciences sectors, leveraging the expertise and industrial platforms of its partners, including Insilico Medicine and the Shanghai Pudong Development and Construction groups. The initiative is expected to enhance innovation, reduce risks in early-stage projects, and drive commercialization within this high-potential ecosystem by integrating capital and industry insights.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.thestandard.com.hk/finance/article/340302/Value-Partners-Insilico-Medicine-Pudong-jointly-launch-AILife-Sciences-CVC-fund
